HR8663-118 · 118th Congress
Signed
Signed Dec 23, 2024DETECT Fentanyl and Xylazine Act of 2024
Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024 This bill provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine. Specifically, the bill provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The bill additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.
VOTE BREAKDOWN
Final passage · 365 politicians tracked
352
YEA
1
NAY
0
PRESENT
12
NOT VOTING
Dem YEA 171Ind YEA 1Rep NAY 1Rep YEA 180
BY PARTY · ✕ NAY ← | → YEA ✓
DEM
0
171
REP
1
180
IND
0
1
MONEY ON THIS BILL
Which donor industries fund each side of the vote — total contributions from that industry to those members, all cycles · plus lobbying activity in affected industries
⬆ YEA voters — top donor industries
- 1. Lawyers & Lobbyists$199.3M
- 2. Securities & Investment$137.4M
- 3. Health Services$136.1M
⬇ NAY voters — top donor industries
- 1. Technology$293K
- 2. Lawyers & Lobbyists$249K
- 3. Health Services$227K
◎ Lobbying activity by issue area
No bill-issue lobbying matches.
Dollar figures are each industry's total contributions to those members across all tracked cycles — not money given for this specific bill. Statistical patterns in public records; correlation, not causation.
LOBBYING ON THIS BILL
3 federal lobbying reports name this bill in their activity descriptions · LDA disclosures
SERGEANTS BENEVOLENT ASSOCIATION OF NEW YORK CITY3 reports
A report naming a bill means the organization disclosed lobbying activity on it — the disclosure does not state a position for or against.
INDIVIDUAL VOTES
Recorded positions for tracked politicians
SPONSORS
Nick LaLota
R-NY · Primary
2 COSPONSORS
DEMOCRATIC● 2 D
SPONSOR FUNDING
Top industries funding LaLota
Party & Leadership21%
Party & Leadership 21% of classified donations
Lawyers & Lobbyists10%
Lawyers & Lobbyists 10% of classified donations
Single-Issue Advocacy9%
Single-Issue Advocacy 9% of classified donations
Real Estate8%
Real Estate 8% of classified donations
Securities & Investment7%
Securities & Investment 7% of classified donations
TRAIL AI
The DETECT Fentanyl and Xylazine Act of 2024 addresses the detection and identification of fentanyl and xylazine in drug supplies, sponsored by Representative Nick LaLota. The bill passed the House with overwhelming bipartisan support, receiving 352 votes in favor and 1 vote against, with Democrats voting 171-0 in support and Republicans voting 180-1 in support. The legislation has been signed into law.
Based on public voting records. Does not imply causation.
TIMELINE
INTRODUCEDJun 7, 2024
PASSED SENATEDec 12, 2024
SIGNEDDec 23, 2024
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.